Biotech companies in China moved swiftly during the early stages of the pandemic to develop COVID-19 vaccine products. Often in partnership with State-sponsored entities, the resulting…
Kintor Pharmaceutical Ltd. received an emergency use authorization (EUA) for proxalutamide in the treatment of COVID-19 in Paraguay. There has been a great deal of skepticism…
Is the Chinese military eying the antiviral drug favipiravir (Avigan®) for use against COVID-19? Apparently so, as a PLA-backed laboratory this year secured the intellectual property rights…
The right-focused, libertarian-centric Judicial Watch, known as a “conservative watchdog” group, recently filed a batch of Freedom of Information Act (FOIA) lawsuits against, among others, the…
As you know, antibody disease enhancement (ADE) was a major concern during the development of the Covid-19 vaccines. These concerns were well-founded and even the…
China’s proclivity toward a nasal-spray vaccine has been present since the onset of the pandemic, since the infections starting spreading in and around Wuhan, China. One…
Israel and China are apparently doubling down on an investment fund based on investor demand and emerging success as a 2016 investment fund known as…
The World Health Organization (WHO) has requested that Chinese vaccine producer Sinovac Biotech (Nasdaq: SVA) share more data as they seek to assess whether to authorize…
Recently, the health minister of the Seychelles—the world’s most vaccinated country against COVID-19—declared that the situation involving COVID-19 became critical again despite the fact that…
TrialSite recently showcased the consolidating contract research organization (CRO) market, with a number of giant organizations now emerging to battle it out on the global…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
